Arrhythmias in hypertrophic cardiomyopathy

Area of Science:

• Cardiology
• Electrophysiology
• Genetic Heart Diseases

Background:

• Supraventricular and ventricular arrhythmias, including nonsustained ventricular tachycardia (NSVT) and ventricular premature beats, are prevalent in hypertrophic cardiomyopathy (HCM).
• NSVT detected via Holter monitoring is linked to an elevated risk of sudden cardiac death (SCD) in HCM patients.
• The efficacy of antiarrhythmic drugs like amiodarone in suppressing these arrhythmias and reducing SCD remains a subject of debate.

Purpose of the Study:

• To evaluate current guidelines regarding the management of arrhythmias in hypertrophic cardiomyopathy.
• To discuss the role of prophylactic antiarrhythmic drug therapy versus implantable cardioverter-defibrillator (ICD) implantation for risk stratification and prevention of sudden cardiac death.
• To explore the utility of various risk stratification methods in identifying HCM patients at risk for sudden cardiac death.

Main Methods:

• Review of existing literature and clinical studies on arrhythmias in HCM.
• Analysis of current treatment strategies, including pharmacological suppression and device implantation.
• Discussion of risk stratification tools such as Holter monitoring, programmed electrical stimulation, and electrocardiogram fractionation.

Main Results:

• Recent evidence suggests that prophylactic amiodarone is not indicated for asymptomatic HCM patients without additional risk factors for SCD.
• Symptomatic patients with sustained ventricular tachycardias or syncope require ICD implantation.
• ICD implantation in asymptomatic HCM patients should be carefully considered and limited to those with multiple SCD risk factors.

Conclusions:

• Management of arrhythmias in HCM should be individualized based on symptoms and risk factors.
• The role of electrophysiological studies and novel risk stratification techniques in asymptomatic HCM patients requires further investigation.
• Current evidence supports a selective approach to ICD implantation, prioritizing patients with established risk factors for sudden cardiac death.